scholarly article | Q13442814 |
P2093 | author name string | Tahiro Shin | |
Stephen D Miller | |||
Lieping Chen | |||
Samantha L Bailey | |||
Bettina Schreiner | |||
P2860 | cites work | B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion | Q22010866 |
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells | Q24291070 | ||
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production | Q24292957 | ||
Human IL-17: a novel cytokine derived from T cells | Q24304404 | ||
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice | Q24670319 | ||
Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction | Q24673269 | ||
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 | ||
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines | Q24678115 | ||
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor | Q28144319 | ||
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice | Q28201627 | ||
PD-L2 is a second ligand for PD-1 and inhibits T cell activation | Q28202471 | ||
Expression of programmed death 1 ligands by murine T cells and APC | Q28214264 | ||
Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus | Q28250589 | ||
The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells | Q28260674 | ||
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes | Q28282689 | ||
Restoring function in exhausted CD8 T cells during chronic viral infection | Q28289222 | ||
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 | ||
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability | Q30480631 | ||
Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis | Q33835268 | ||
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo | Q34049368 | ||
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 | Q34145393 | ||
PD-1 inhibits antiviral immunity at the effector phase in the liver | Q34535179 | ||
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis | Q34535189 | ||
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells | Q34578170 | ||
PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis | Q34593300 | ||
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses | Q34650346 | ||
Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor | Q35111360 | ||
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. | Q36228158 | ||
Tissue expression of PD-L1 mediates peripheral T cell tolerance. | Q36228541 | ||
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis | Q36365105 | ||
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. | Q36370918 | ||
Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor | Q36376676 | ||
In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses | Q36402989 | ||
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection | Q36441358 | ||
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. | Q36457107 | ||
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection | Q36737159 | ||
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells | Q36986702 | ||
Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production | Q40395261 | ||
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. | Q40453661 | ||
Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. | Q40460778 | ||
NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. | Q40493871 | ||
B7 family molecules are favorably positioned at the human maternal-fetal interface | Q40668007 | ||
Exacerbations of multiple sclerosis in patients treated with gamma interferon | Q40797798 | ||
Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis | Q40814343 | ||
B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis | Q44822884 | ||
Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice | Q45740050 | ||
Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis | Q47581510 | ||
B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. | Q47926434 | ||
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses | Q48186068 | ||
The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system | Q48554549 | ||
Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. | Q48974951 | ||
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. | Q49014751 | ||
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). | Q52519041 | ||
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. | Q53015646 | ||
Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. | Q53722655 | ||
T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. | Q53897545 | ||
De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. | Q53974447 | ||
Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. | Q54702814 | ||
B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism | Q56903535 | ||
CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis | Q56905834 | ||
Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE | Q57042714 | ||
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE | Q71457188 | ||
Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis | Q73330348 | ||
Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis | Q79209903 | ||
Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF | Q82459138 | ||
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis | Q82732353 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2706-2717 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | European Journal of Immunology | Q5412727 |
P1476 | title | PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. | |
P478 | volume | 38 |
Q56889692 | A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity |
Q36408695 | A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke |
Q42011483 | Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants |
Q26774826 | Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS? |
Q33592911 | B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells |
Q34122678 | B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance |
Q37679878 | B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms |
Q35113362 | CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function |
Q42577315 | CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1 |
Q47139579 | CD4+T cell specific B7-H1 selectively inhibits proliferation of naïve T cells and Th17 differentiation in experimental autoimmune encephalomyelitis |
Q33873566 | CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease |
Q39761212 | Co-inhibitory molecules: Controlling the effectors or controlling the controllers? |
Q36919720 | Co-stimulatory and Co-inhibitory Pathways in Autoimmunity. |
Q28080920 | Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus |
Q37684852 | Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut? |
Q64991932 | Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function. |
Q92886704 | Depletion of PD-1-positive cells ameliorates autoimmune disease |
Q54715235 | ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. |
Q34065039 | GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation. |
Q64076635 | Glial Cell Expression of PD-L1 |
Q40119805 | Helminth Products Potently Modulate Experimental Autoimmune Encephalomyelitis by Downregulating Neuroinflammation and Promoting a Suppressive Microenvironment. |
Q41511974 | High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis |
Q35586871 | Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis |
Q43466708 | IL-27 renders DC immunosuppressive by induction of B7-H1. |
Q47986213 | Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives |
Q36049534 | Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes |
Q38614544 | Maintenance of PD-1 on brain-resident memory CD8 T cells is antigen independent. |
Q37333298 | Microglia: gatekeepers of central nervous system immunology. |
Q36661068 | Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis |
Q34094680 | PD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitis |
Q34378721 | PD-L1hi retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells |
Q38930119 | Potential targeting of B7-H4 for the treatment of cancer. |
Q43444916 | Pregnancy-specific glycoprotein 1a activates dendritic cells to provide signals for Th17-, Th2-, and Treg-cell polarization |
Q40106036 | Programmed Death Ligand-1 on Microglia Regulates Th1 Differentiation via Nitric Oxide in Experimental Autoimmune Encephalomyelitis |
Q37413039 | Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity |
Q37218368 | Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response |
Q88506865 | Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway |
Q38273234 | Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke |
Q26997105 | Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders |
Q88183775 | Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin |
Q48786036 | Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. |
Q37781079 | Role of PD-L1 and PD-L2 in allergic diseases and asthma |
Q33685495 | Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation |
Q27687098 | Targeting dendritic cell function during systemic autoimmunity to restore tolerance |
Q36841260 | Targeting the B7 family of co-stimulatory molecules: successes and challenges |
Q26859307 | The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy |
Q37583514 | The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation |
Q34268029 | The role of antigen presenting cells in multiple sclerosis |
Q38083804 | The role of pregnancy-specific glycoprotein 1a (PSG1a) in regulating the innate and adaptive immune response |
Q28304161 | The role of the PD-1 pathway in autoimmunity and peripheral tolerance |
Q35175866 | Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. |
Q35610755 | Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE. |